Abrocitinib, tralokinumab and upadacitinib for treating moderate-to-severe atopic dermatitis
Background Atopic dermatitis is a chronic relapsing inflammatory skin condition. One of the most common skin disorders in children, atopic dermatitis typically manifests before the age of 5 years, but it can develop at any age. Atopic dermatitis is characterised by dry, inflamed skin accompanied by...
Salvato in:
| Autori principali: | , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
NIHR Journals Library
2024-01-01
|
| Serie: | Health Technology Assessment |
| Soggetti: | |
| Accesso online: | https://doi.org/10.3310/LEXB9006 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|